Filing Summary
Registrant: GX Acquisition Corp.; the supplied metadata identifies Celularity Inc., but the filing is issued by GX Acquisition Corp.
Reporting period and event: Form 8-K filed January 4, 2021, reporting matters voted on at the December 29, 2020 annual meeting of stockholders.
Business Context and Corporate Actions
- Stockholders re-elected Paul S. Levy as a Class I director, to serve until the 2023 annual meeting or until a successor is elected and qualified.
- Stockholders ratified Marcum LLP as the independent registered public accounting firm for the year ending December 31, 2020.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial performance metrics.
Voting Results
| Proposal | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Election of Paul S. Levy | 18,328,464 | 0 | 2,821,305 | N/A |
| Ratification of Marcum LLP | 21,109,546 | 1 | 40,222 | 0 |
Material Changes, Outlook, and Risks
The filing reports no material changes in financial condition, guidance, outlook, management commentary, contingencies, or unusual financial items. It is limited to annual-meeting voting results.
Investor Verification Items
- Confirm that the filing pertains to GX Acquisition Corp., not Celularity Inc.
- Verify the director-election term and the final vote totals.
- Confirm Marcum LLP’s appointment as auditor for the year ending December 31, 2020.
- Review subsequent filings for any transaction, business-combination, or corporate-name changes involving GX Acquisition Corp. and Celularity Inc.